Scientific Program – ART/IVF/Infertility

Friday, November 22, 2024

Hall A and Hall B

08:30-09:00 GOOD MORNING LISBON PLENARY LECTURE HALL A
Chairpersons Zion Ben Rafael, Israel
Luís Ferreira Vicente
, Portugal
08:30-09:00 Sporadic and recurrent miscarriage: Preventive tools
TBC

 

09:00-10:30 OVARIAN STIMULATION HALL A
Capsule The first step in IVF remains in the shade between science and art
Chairpersons
09:00-09:20 The optimal number of oocytes we should aim for with ovarian stimulation
Bart Fauser, Netherlands
09:20-09:55

09:20-09:30
09:30-09:40
09:40-09:55

Debate: The ovarian stimulation protocol: Does the FSH type matter, alfa, beta, delta?

Yes: TBA
No: Frank Broekmans, Netherlands
Discussion

09:55-10:30

09:55-10:05
10:05-10:15
10:15-10:30

Debate: Adding hCG/LH to the FSH for ovarian stimulation: Are we done with this topic?

Pro: Claus Yding Andersen, Denmark
Con: Edgardo Somigliana, Italy
Discussion

 

10:30-10:50 Coffee break, visit the exhibition, and e-poster viewing

 

10:50-12:20 IVF IN OLDER WOMEN HALL A
Capsule The high success rate in IVF had skipped the older age women – why?
Chairpersons Teresa Almeida Santos, Portugal
TBA
10:50-11:10 The true prevalence of recurrent aneuploidy
Paul Pirtea, France 
11:10-11:45

11:10-11:20
11:20-11:30
11:30-11:45

Debate: ART for unexplained infertility in older women

Yes: TBA
No: Edgardo Somigliana, Italy 
Discussion

11:45-12:20

11:45-11:55
11:55-12:05
12:05-12:20

Debate: Standardization of IVF cycle protocols is advisable

Pro: Frank Broekmans, Netherlands
Con: Norbert Gleicher, USA
Discussion

 

12:20-12:25 Short break

 

12:25-13:25 INDUSTRY SUPPORTED SESSION HALL A

 

13:25-14:10 Lunch break, visit the exhibition, e-poster viewing, and moderated e-poster sessions

 

14:10-15:10 INDUSTRY SUPPORTED SESSION HALL A

 

15:10-15:15 Short break

 

15:15-16:45 ENDOMETRIUM AND EMBRYO TRANSFER HALL A
Capsule
Chairpersons Ricardo Santos, Portugal
Edgardo Somigaliana, Italy
15:15-15:50

15:15-15:25
15:25-15:35
15:35-15:50

Debate: Is thin endometrium a predictor for poor ART outcomes?

Yes: Shari Mackens, Belgium
No: Paul Pirtea, France
Discussion

15:50-16:10

The endometrium in polycystic ovary syndrome
Johannes Ott, Austria

16:10-16:25

Home based monitoring before frozen embryo transfer
Shari Mackens, Belgium

16:25-16:45

The changing dogma of FET: HRT should stop being the first choice and only be done when natural cycles are not possible
Samuel Santos-Ribeiro, Portugal

 

16:45-17:05 Coffee break, visit the exhibition, and e-poster viewing

 

17:05-18:35 PGT-A: BENEFITS AND RISKS HALL A
Capsule PGT – Lucrative, costly, can commonly used – is it also needed?
Chairpersons Teresa Almeida Santos, Portugal
Norbert Gleicher, USA

17:05-17:50

17:05-17:20
17:20-17:35
17:35-17:50

Debate: Is PGT-A a safe procedure in 2024?

Yes: Paul Pirtea, France
No: Sebastiaan Mastenbroek, Netherlands
Discussion

17:50-18:35

17:50-18:05
18:05-18:20
18:20-18:35

Debate: Should we consider PGT-P?

Yes: Darren Griffin, UK
No:  Rita Vassena, Spain
Discussion


HALL B

08:30-09:00 GOOD MORNING LISBON PLENARY LECTURE HALL A

 

09:00-10:30 LABORATORY WORK HALL B
Capsule Sometimes routine is good, sometimes is dull…Do we need to fundamentally change how we approach ICSI and embryo culture, or we are fine with current trends and protocols?
Chairpersons Ana Sousa Ramos, Portugal
TBA
09:00-09:45

09:00-09:15
09:15-09:30
09:30-09:45

DebateShould we question the composition of IVF media culture?

Yes: Sebastiaan Mastenbroek, Netherlands
No: TBC
Discussion

09:45-10:30

09:45-10:00
10:00-10:15
10:15-10:30

Debate: ICSI for all?

Yes: Aïda Pujol, Spain
No: Rita Vassena, Spain
Discussion

 

10:30-10:50 Coffee break, visit the exhibition, and e-poster viewing

 

10:50-12:20 MITOCHONDRIA AND REPRODUCTION HALL B
Capsule We could not live without them, and yet for many in IVF the mitochondria remain a mystery. This session dives into the role of mitochondria in defining oocyte and embryo quality, and overall health
Chairpersons João Ramalho-Santos, Portugal
TBA
10:50-11:20

Mitochondrial variants and IVF outcomes in newborns
Claudia Spits, Belgium

11:20-11:50

PGT-M for mitochondrial diseases: For whom and how
Bert Smeets, Netherlands

11:50-12:20

Maternal spindle transfer for the avoidance of mitochondrial disease
Nuno Costa-Borges, Spain

 

12:20-12:25 Short break

 

12:25-13:25 INDUSTRY SUPPORTED SESSION HALL A
(overflow from Hall A)

 

13:25-14:10 Lunch break, visit the exhibition, e-poster viewing, and moderated e-poster sessions

 

14:10-15:10 INDUSTRY SUPPORTED SESSION HALL B
(overflow from Hall A)

 

15:10-15:15 Short break

 

15:15-16:45 HAS SEMEN ANALYSIS LOST HIS RELEVANCE? HALL B
Capsule Can we do any better beyond using ICSI
Chairpersons Rita Vassena, Spain
TBC
15:15-15:35 DNA fragmentation
João Ramalho-Santos, Portugal
15:35-15:55 Swimming patterns
Jackson Kirkman-Brown, UK
15:55-16:15 Association with reproductive outcomes
Aïda Pujol, Spain
16:15-16:45 Countercurrent lecture: Can we improve semen quality?
Martin Blomberg Jensen, Denmark

 

16:45-17:05 Coffee break, visit the exhibition, and e-poster viewing

 

17:05-18:35 NEW PREDICTORS OF IVF SUCCESS? HALL B
Capsule From uterine volume to protein biomarkers, here we explore upcoming predictors of IVF success and their role in personalizing reproductive care
Chairpersons Luís Ferreira Vicente, Portugal
Rita Vassena, Spain
17:05-17:35 Uterine volume and endometrial compaction as predictors of implantation
Baris Ata, Turkey
17:35-18:05 The endometrial proteome and infertility
TBC
18:05-18:35 Seminal plasma biomarkers of successful IVF
Signe Altmäe, Spain

 

Skip to content